Kidney Function Tests Market Size to Reach $1.9 Billion by 2025: Grand View Research, Inc.

Wednesday, April 12, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

SAN FRANCISCO, April 12, 2017 /PRNewswire/ --

The global kidney function tests market is expected to reach

USD 1.9 billion by 2025, according to a new study by Grand View Research, Inc. The growing prevalence of Chronic Kidney Diseases (CKD) and renal failure is presumed to be responsible for the high urgency to use kidney function
tests, which is anticipated tobroaden the scope for growth throughout the forecast period. In addition, expanding base of diabetic population, which is highly susceptible to the aforementioned diseases, is predicted to impel the demand further over the coming years. Consequently, resultant high sample volume will require high capability kidney function testing devices, which is believed to present the market with significant growth potential opportunities.

     (Logo: )

In addition, growing awareness with respect to diagnostic benefits associated with kidney function tests is also anticipated to be one of the high impact rendering drivers for this market. Emergence of technologically advanced products, such as automated analyzers, has led to refinement of current real-time point-of-care testing capabilities and, therefore, creates lucrative growth opportunities for the market. Furthermore, presence of public as well private healthcare organizations consistently striving to support diagnosis and management of CKD through a range of programs and initiatives is expected to create potential demand.

Browse full research report with TOC on "Kidney Function Tests Market Analysis By Product (Dilution & Concentration, Clearance, Urine, Imaging Tests), By End-use (Hospitals, Diagnostic Laboratories, Academic Research Laboratories), And Segment Forecasts, 2014 - 2025" at:

Further key findings from the report suggest: 

  • Imaging tests are expected to exhibit lucrative CAGR owing to increasing adoption in wide array of clinical applications. The high penetration can be attributed to efficient renal function risk assessment due to abnormal results generated through other tests
  • Diagnostic laboratories are anticipated to exhibit lucrative CAGR during the forecast period owing to increasing preference for point-of-care testing by clinicians
  • In 2016, North America held a dominant share of the global kidney function tests market, as a consequence of increasing local presence of prominent companies undertaking competitive sustainability strategies
  • Asia Pacific is anticipated to grow at an exponential CAGR owing to unmet needs of patients, continuous infrastructural & technological upgradation, and increasing healthcare expenditure
  • Some key participants such as Abbott Laboratories; Merck Millipore; Alere, Inc.; and Quest Diagnostics are implementing various competitive strategies, such as new product development & frequent product approvals, to maintain their position in the market
  • For instance, in March 2015, metropolis announced the launch of a kidney function test, a PLA2R antibody test, that detects and evaluates intensity of membranous nephropathy

Browse related reports by Grand View Research: 

  • Cancer biomarker Market -
  • Diabetes Treatment Market -
  • Asthma & COPD Market -
  • Companion Diagnostics Market -

Grand View Research has segmented the kidney function tests market on the basis of product, end use, and region: 

  • Kidney Function Tests Product Outlook (Revenue, USD Million, 2014 - 2025) 
    • Dilution & Concentration Tests
    • Clearance Tests
    • Urine Tests
    • Imaging Tests
  • Kidney Function Tests End-Use Outlook (Revenue, USD Million, 2014 - 2025) 
    • Hospitals
    • Diagnostic Laboratories
    • Academic Research Laboratories
    • Others
  • Kidney Function Tests Regional Outlook (Revenue, USD Million, 2014 - 2025) 
    • North America
      • U.S.
      • Canada
    • Europe
      • UK
      • Germany
    • Asia Pacific
      • Japan
      • China
      • India
    • Latin America
      • Mexico
      • Brazil
    • MEA
      • South Africa

Read Our Blog: Kidney function tests: Advanced tool for chronic kidney disease diagnosis and assessment

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email:


SOURCE Grand View Research, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store